Why is Shree Ganesh Bio falling/rising?

As of 23-Sep, Shree Ganesh Biotech India Ltd is experiencing a decline in its stock price, currently at 0.77, reflecting a decrease of 0.01 or 1.28%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 16% compared to the 5-day average. The stock has underperformed significantly over various periods, with a year-to-date decline of 25.96% and a staggering 58.15% drop over the past three years. The company is also facing operational challenges, including weak long-term fundamental strength and a negative EBITDA, which further contribute to its declining stock performance.
In the broader market context, Shree Ganesh Biotech's short-term performance has been notably worse than the benchmark Sensex, which has only declined by 0.34% over the past week while the stock itself has dropped by 2.53%. This underperformance is compounded by the company's inability to generate significant returns, as evidenced by a low average return on equity of 2.52% and a poor EBIT to interest ratio of 0.97. The overall market conditions appear to be more favorable, but Shree Ganesh Biotech's operational losses and weak profitability metrics are leading to a lack of investor confidence, resulting in the stock's downward trajectory.